Researchers at London Health Sciences Center Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to treat renal cell carcinoma (kidney cancer) by inserting microscopic beads filled with radiation directly into blood vessels surrounding cancerous tumors. The goal is to improve patient outcomes through a new treatment option.
This article was originally published on MedicalXpress.com